We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Which Is the Optimal Suture for Use in the Abdomen?

By HospiMedica International staff writers
Posted on 14 Aug 2012
A new study suggests that Polyglactin 910 (Vicryl) may be the optimal type of suture to use in the peritoneal cavity.

Researchers at Tokai University School of Medicine (Tokyo, Japan) conducted a study to explore the optimal suture materials for use in the peritoneal cavity, based on the formation of adhesions and abscesses under clean and contaminated conditions. More...
To do so, the researchers incised the parietal peritoneum and muscle layer of rats. The incision was followed by interrupted suturing in the clean group. A suspension of E. coli was sprayed onto the incision in the contaminated group, followed by interrupted suturing. Four types of sutures were used; nonabsorbable multifilament silk, absorbable multifilament Vicryl, absorbable monofilament Polydioxanone (PDS), and Poliglecaprone 25 (Monocryl).

The rats were sacrificed at 2, 4, or 8 weeks after the surgery. The researchers then examined the incidence of adhesions, and found it was low in the clean group with Polyglactin 910. The incidence of adhesions was 96 % or higher regardless of the suture type in the contaminated group. The incidence of severe adhesions was low with Polyglactin 910 and Poliglecaprone 25 and significantly higher with Polydioxanone in the contaminated group. The incidence of abscess formation around the silk was significantly higher than the other three types of sutures in the contaminated group. The study was published in the July 14, 2012, issue of Surgery Today.

“Polyglactin 910 was less likely to form adhesions than the other three types of sutures under both conditions, suggesting that Polyglactin 910 may be the optimal type of suture to use in the peritoneal cavity,” concluded lead author Kenji Ishikawa, PhD, and colleagues. “The reduction of the tensile strength with time did not differ significantly between sutures exposed to contaminated and clean conditions, even for the absorbable sutures.”

Vicryl is an absorbable, synthetic, braided suture, manufactured by Ethicon (Atlanta, GA, USA), a subsidiary of Johnson and Johnson (New Brunswick, NJ, USA). It is indicated for soft tissue approximation and ligation. The suture has a smooth, low friction proprietary coating that reduces tissue drag, and holds its tensile strength for approximately three to four weeks in tissue, completely absorbed by hydrolysis within 60 days.

Vicryl and other polyglycolic acid sutures may be treated to undergo more rapid breakdown in rapidly healing tissues such as mucous membrane, or impregnated with triclosan to provide antimicrobial protection of the suture line. Although the name Vicryl is a trademark of Ethicon, the term vicryl has been used generically referring to any synthetic absorbable suture made primarily of polyglycolic acid.

Related Links:

Tokai University School of Medicine
Ethicon
Johnson and Johnson



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Half Apron
Demi
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.